• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人百日咳疫苗接种:临床医生最新指南

Pertussis Vaccination for Adults: An Updated Guide for Clinicians.

作者信息

See Kay Choong

机构信息

Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore 119074, Singapore.

出版信息

Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.

DOI:10.3390/vaccines13010060
PMID:39852839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11768464/
Abstract

Pertussis, or whooping cough, is a highly contagious respiratory infection caused by the Gram-negative bacterium . Although traditionally associated with children, pertussis is increasingly prevalent among adults, particularly those with comorbidities or weakened immune systems, where it can lead to severe complications. Diagnosing pertussis in adults can be challenging due to its nonspecific symptoms, underreporting, and the limited sensitivity of available diagnostic tests. While treatment with macrolides is generally effective, it may not significantly alter the clinical course of the disease, and growing concerns about macrolide resistance are emerging. Vaccination remains the cornerstone of prevention, offering proven immunogenicity, efficacy, and safety. However, vaccination uptake remains low, partly due to limited patient awareness and insufficient prioritization by healthcare professionals. This review aims to provide clinicians with critical insights into pertussis epidemiology, vaccination strategies, and the latest guideline recommendations, empowering them to engage in meaningful discussions with adult patients and advocate for increased vaccination to combat this often-overlooked infection.

摘要

百日咳,又称小儿咳嗽,是由革兰氏阴性菌引起的一种高度传染性的呼吸道感染。虽然传统上与儿童有关,但百日咳在成年人中越来越普遍,尤其是那些患有合并症或免疫系统较弱的人,在这些人群中,百日咳可能会导致严重的并发症。由于成人百日咳的症状不具特异性、报告不足以及现有诊断测试的敏感性有限,因此在成人中诊断百日咳具有挑战性。虽然使用大环内酯类药物治疗通常有效,但它可能不会显著改变疾病的临床进程,并且人们对大环内酯类耐药性的担忧日益增加。疫苗接种仍然是预防的基石,具有已证实的免疫原性、有效性和安全性。然而,疫苗接种率仍然很低,部分原因是患者意识有限以及医疗保健专业人员的重视不足。本综述旨在为临床医生提供关于百日咳流行病学、疫苗接种策略和最新指南建议的重要见解,使他们能够与成年患者进行有意义的讨论,并倡导增加疫苗接种以对抗这种经常被忽视的感染。

相似文献

1
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.成人百日咳疫苗接种:临床医生最新指南
Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.
2
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.在治疗阻塞性气道疾病的成年人中,降低抗原破伤风、白喉和无细胞百日咳疫苗的免疫原性和安全性。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2159731. doi: 10.1080/21645515.2022.2159731. Epub 2023 Feb 6.
3
Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.在小鼠模型中对一种新型低剂量破伤风白喉无细胞百日咳疫苗针对百日咳博德特氏菌的安全性和有效性评估。
BMC Infect Dis. 2017 Apr 4;17(1):247. doi: 10.1186/s12879-017-2369-x.
4
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.老年人和高危人群中百日咳疫苗接种的需求:来自亚太地区发达经济体的观点。
Expert Rev Vaccines. 2021 Dec;20(12):1603-1617. doi: 10.1080/14760584.2021.1990759. Epub 2021 Nov 22.
5
Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.Tdap5 疫苗(Covaxis):作为一种单剂疫苗,用于预防儿童(4 岁)、青少年和成人破伤风、白喉和百日咳的用途综述。
BioDrugs. 2010 Dec 1;24(6):387-406. doi: 10.2165/11206000-000000000-00000.
6
Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged ≥4 years), adolescents, and adults.聚焦 Tdap₅ 疫苗(Covaxis®)作为预防破伤风、白喉和百日咳的单一加强免疫接种:用于儿童(≥4 岁)、青少年和成人。
Paediatr Drugs. 2011 Apr 1;13(2):133-5. doi: 10.2165/11206990-000000000-00000.
7
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.吸附无细胞百白破灭活、全细胞百日咳和破伤风联合疫苗(Boostrix®):作为单剂加强免疫的特性和用途介绍。
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
8
Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel.预防成人破伤风、白喉和百日咳:免疫实践咨询委员会(ACIP)关于使用破伤风类毒素、吸附白喉类毒素和无细胞百日咳疫苗的建议,以及在医疗感染控制实践咨询委员会(HICPAC)支持下,ACIP关于医护人员使用破伤风类毒素、低剂量白喉类毒素和无细胞百日咳疫苗(Tdap)的建议。
MMWR Recomm Rep. 2006 Dec 15;55(RR-17):1-37.
9
Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).预防青少年破伤风、白喉和百日咳:破伤风类毒素、白喉类毒素含量降低的无细胞百日咳疫苗的使用——免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.
10
Pertussis Epidemiology in Children: The Role of Maternal Immunization.儿童百日咳流行病学:母体免疫的作用。
Vaccines (Basel). 2024 Sep 9;12(9):1030. doi: 10.3390/vaccines12091030.

引用本文的文献

1
Atypical Presentation of Bordetella pertussis in a Six-Month-Old with Cleaved Lymphocytes and Mild Respiratory Distress.一名6个月大婴儿感染百日咳博德特氏菌的非典型表现,伴有核裂淋巴细胞和轻度呼吸窘迫。
Cureus. 2025 Jun 5;17(6):e85395. doi: 10.7759/cureus.85395. eCollection 2025 Jun.
2
A budget impact analysis of adult immunization with tetanus, diphtheria, and pertussis vaccination for the prevention of pertussis in at-risk populations in Colombia.在哥伦比亚高危人群中使用破伤风、白喉和百日咳疫苗进行成人免疫以预防百日咳的预算影响分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2507885. doi: 10.1080/21645515.2025.2507885. Epub 2025 Jun 5.
3
Exploiting subtractive genomics to identify novel drug targets and new immunogenic candidates against : an study.利用消减基因组学鉴定新型药物靶点和针对……的新免疫原性候选物:一项……研究
Front Bioinform. 2025 May 13;5:1570054. doi: 10.3389/fbinf.2025.1570054. eCollection 2025.

本文引用的文献

1
Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany.成人百日咳疫苗接种:来自美国、法国和德国的医生的行为研究。
BMC Prim Care. 2024 Nov 26;25(1):402. doi: 10.1186/s12875-024-02647-3.
2
Seroepidemiology of pertussis immunity in five provinces of China: A population-based, cross-sectional study.中国五个省份百日咳免疫的血清流行病学:基于人群的横断面研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2417532. doi: 10.1080/21645515.2024.2417532. Epub 2024 Nov 15.
3
Enhancing COVID-19 Vaccination Awareness and Uptake in the Post-PHEIC Era: A Narrative Review of Physician-Level and System-Level Strategies.加强新冠疫情全球紧急状态结束后时代的新冠疫苗接种意识与接种率:医生层面和系统层面策略的叙述性综述
Vaccines (Basel). 2024 Sep 11;12(9):1038. doi: 10.3390/vaccines12091038.
4
Letter to the editor: Is the acellular pertussis vaccine driving the increase in severe whooping cough cases in children?致编辑的信:无细胞百日咳疫苗是否导致儿童严重百日咳病例增加?
Euro Surveill. 2024 Sep;29(37). doi: 10.2807/1560-7917.ES.2024.29.37.2400574.
5
Global tendency and frontiers of research on pertussis from 2000 to 2023: A bibliometric and visual analysis.全球 2000-2023 年百日咳研究的趋势和前沿:文献计量学和可视化分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2392334. doi: 10.1080/21645515.2024.2392334. Epub 2024 Sep 5.
6
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
7
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.中国 ptxP3 大环内酯类耐药博德特氏菌 MT28 克隆引起的 COVID-19 后百日咳疫情抬头、年龄偏移和疫苗逃逸。
Clin Microbiol Infect. 2024 Nov;30(11):1439-1446. doi: 10.1016/j.cmi.2024.08.016. Epub 2024 Aug 28.
8
Resurgence of , including one macrolide-resistant isolate, France, 2024.法国 2024 年出现了 ,包括一个耐大环内酯的分离株。
Euro Surveill. 2024 Aug;29(31). doi: 10.2807/1560-7917.ES.2024.29.31.2400459.
9
Adult vaccination coverage in the United States: A database analysis and literature review of improvement strategies.美国成人疫苗接种覆盖率:数据库分析和改进策略文献综述。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2381283. doi: 10.1080/21645515.2024.2381283. Epub 2024 Jul 30.
10
Tetanus, pertussis, and diphtheria vaccination coverage in older adults, Australia, 2023: analysis of Australian Immunisation Register data.2023年澳大利亚老年人破伤风、百日咳和白喉疫苗接种覆盖率:澳大利亚免疫登记数据分析
Med J Aust. 2024 Aug 19;221(4):224-225. doi: 10.5694/mja2.52389. Epub 2024 Jul 17.